Navigation Links
BioVex Announces Publication of Phase 2 Melanoma Results With OncoVEX (GM-CSF) in the Journal of Clinical Oncology
Date:11/2/2009

WOBURN, Mass., Nov. 2 /PRNewswire/ -- BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that the data from its completed Phase 2 clinical study of OncoVEX (GM-CSF) for the treatment of advanced melanoma has been published in the Journal of Clinical Oncology (JCO). The previously announced top line results report a high objective durable response rate and a high complete response rate, combined with a relatively benign side effect profile. Overall, 20% of patients ultimately achieved a complete response and 28% of patients achieved an overall objective response (complete response or partial response). Ninety two percent of the responses are durable as defined as lasting at least 6 months, and the majority are ongoing, with a range of 18 to 40 months. Responses were observed in patients with all stages of disease, including the complete resolution of visceral deposits. The study results were made available online today on the JCO website and will be published in the December 2009 print edition. The Phase 2 study was led by Dr. Neil N. Senzer of The Mary Crowley Cancer Research Center, Dallas, TX.

"The high percentage of durable complete responses in this study suggests that this therapy has the potential to provide long term benefit to responding patients, potentially including cures," said Dr. Neil N. Senzer of The Mary Crowley Cancer Research Center, Dallas, TX. "OncoVEX (GM-CSF) offers significant promise in providing a real advance in the treatment of a disease where there are few if any effective treatment options, particularly when coupled with a relatively benign side effect profile."

"In addition to use in more advanced patients, these encouraging results suggest OncoVEX (GM-CSF) has the potential to be used to intervene in the early stages of metastatic disease where it might act to reduce the high rate of progression to widespread diseas
'/>"/>

SOURCE BioVex Inc
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting
2. BioVex Announces Regulatory Clearance to Commence a Clinical Study With ImmunoVEX HSV2; A Vaccine Candidate for Genital Herpes
3. BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
4. BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
5. BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO
6. PDL BioPharma Announces Closing of $300,000,000 Securitization Transaction
7. Arcadia Resources Announces Webcast of Its Fiscal 2010 Second Quarter Conference Call
8. ATS Medical Announces First in World Human Robotic Endoscopic Aortic Valve Replacement
9. Nuevolution Announces Receipt of Milestone Payment From Merck & Co., Inc.
10. Stryker Announces Change in Chairman of the Board of Directors
11. Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013 Ranbaxy ... Sankyo Co., Ltd. (hereafter, Daiichi Sankyo), announced on ... in recent years to address past conduct under ... Daiichi Sankyo continues to support ... the conduct of the past which led to ...
(Date:5/22/2013)... 2013  Grifols, ein globales Unternehmen der ... , Spanien, präsentierte die Ergebnisse einer ... von PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) den Spiegel des ... ein Niveau anhebt, das innerhalb des für ... ist eine lebensbedrohliche, genetische Erkrankung, bei der ...
(Date:5/22/2013)... Israel , May 22, 2013  Rosetta Genomics ... and provider of microRNA-based molecular diagnostics, announces that ... Executive Officer of Rosetta Genomics, will deliver a corporate ... from June 3-6, 2013 in New York City.  Mr. ... th at 2:00 p.m. Eastern time. ...
Breaking Medicine Technology:Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3
... of Americans who are obese will increase to 164 million, ... years, a recent study says. 1 800 GET THIN ... individuals suffering from obesity and associated diseases resulting from obesity. ... and professionals we work with, is to attain a healthier ...
... a Nevada corporation ("MusclePharm" or the "Company") (OTCBB: MSLP), ... announce MusclePharm,s preliminary financial results for the third quarter ... basis, the Company expects unaudited gross revenues for the ... an increase of 305% as compared to gross revenues ...
Cached Medicine Technology:1-800-GET-THIN Agrees With Report Calling for Better Eating Habits 2MusclePharm Announces Preliminary Third Quarter 2011 Results 2MusclePharm Announces Preliminary Third Quarter 2011 Results 3
(Date:5/22/2013)... Encino, CA (PRWEB) May 22, 2013 Dr. ... alternative to painful scalpel surgery with the Laser Assisted New ... Satlin is raising awareness about the connections between gum disease ... health concerns in the United States today, and is linked ... levels of bacteria found in the infected gum pockets. ...
(Date:5/22/2013)... 22, 2013 Hosted by the California ... dental clinic provided more than $1.6 million in charitable ... in San Jose. , The California Dental Association ... to provide free dental services and oral health education ... the third clinic held by CDA and CDAF in ...
(Date:5/22/2013)... there is a gender gap when it comes to ... that does not appear to exist in children in ... levels of self-regulation than boys. Self-regulation is defined as ... directions, and persist on a task. It has been ... studies by Oregon State University researchers. , In ...
(Date:5/22/2013)... Bodybuilding.com is giving back to those ... Bodybuilding.com will be donating $1 from EVERY purchase made between ... are extremely grateful for the men and women who have ... CEO and founder of Bodybuilding.com. “It’s an honor to give ... Hire Heroes USA is an amazing organization that supports our ...
(Date:5/22/2013)... previous research that suggests umpire discrimination exists in ... between researchers at U-M and the universities of ... argument over whether MLB umpires discriminate by calling ... race. It found little statistical evidence to support ... sport management at the U-M School of Kinesiology. ...
Breaking Medicine News(10 mins):Health News:For Stroke Awareness Month, Dr. Andrew Satlin is Raising Awareness of the Connections Between Gum Disease and Stroke and Offers Encino, CA Laser Gum Surgery for Treatment 2Health News:Two-day San Jose Dental Clinic Provides More Than $1.6 Million in Care 2Health News:'Boys will be boys' in US, but not in Asia 2Health News:'Boys will be boys' in US, but not in Asia 3Health News:In the Spirit of Memorial Day, Bodybuilding.com is Donating a Portion of Their Sales to Hire Heroes 2Health News:U-M study challenges notion that umpires call more strikes for pitchers of same race 2
... to launch her diet plan, which recommends eating of bread to reduce ... The Bread for Life Diet: The High-on-Carbs Weight Loss Plan.// ... slices a day for women and 16 slices a day for men ... program. ,The bread is not a gimmick. Rather it is ...
... probably meant embracing death together for a married couple in ... of dying a little of humiliation everyday. ,In an act ... death his 25-year-old wife and then hanged himself in the ... , ,Probir and Basanti Sarkar were a happy ...
... lose weight for health, it is equally important to lose ... servings of fruits, vegetables, whole grains and other such nutritious ... adapt and follow and is more effective than the conventional ... it! ,A low-fat, plant-based diet has been found to ...
... the second most common forms of cancer, and is associated ... colon cancer. The presence of benign growths in the colon, ... of the factors that predispose to colon cancer. The disease ... trying to develop a practical test to predict a person's ...
... Research suggests that 25% of the MRSA infections in the ... the hospital. The research was published in the latest ... many sites; one serious form of infection is that in ... scheme counts MRSA bacteremia by hospital trust, but it has ...
... News from the British Science Festival reports that Mental exercises ... Brain exercises such as crossword puzzles, Su doku and aerobic ... a number puzzle in which a number has to placed ... most frequently a 9×9 grid made up of 3×3 subgrids ...
Cached Medicine News:Health News:Weight loss accomplished by high carbohydrate, vegan diet 2Health News:Risk of colon cancer to be assessed by simple blood test 2Health News:Mental exercises reduces brain ageing 2
The Riboprinter microbial characterization system provides the speed, accuracy and resolution needed to identify microorganisms and characterize them efficiently and consistently. These determination...
A versatile plate washer and/or dispenser that aspirates from the top down without immersing the aspirating tubes in the well, ensuring overflow protection. 5 programmable protocols....
The Finstrip 4 is an effective and reliable microplate washer offering high performance, simplicity and ease of use....
... 1575 immunowash microplate washer ... needle position to perform ... maximize wash efficiency. This ... choice of wash that ...
Medicine Products: